With the control beads, fluorescent intensity in the plasma sample from the COVID-19 patient and the commercial anti-RBD IgG or IgM was close to the blank control and the plasma from the healthy blood donor (Fig. 3b, d). The gene discussed is CD40LG; the disease is COVID-19.